Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial
Studies are exploring its potential benefits in cardiovascular health, non-alcoholic fatty liver disease (NAFLD), and neurodegenerative disorders
L., Jeppesen, O
Eligible Medicare beneficiaries will be able to obtain super-popular, but pricey GLP-1 medications for $50 a month, starting July 1, Dr
9.Henney AE, Heague M, Riley DR, et al
Using a pooled payment rate across all three categories would result in a rate of approximately $65.85/cm 2 , while splitting the categories to pay the PMA category using the combined product utilization patterns and the 510(k) and 361 HCT/P categories using the OPPS utilization patterns would result in rates of approximately $259.47/cm 2 and $125.38/cm 2 respectively